FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, namely, to a novel pestivirus. Proposed are an isolated polynucleotide for inducing an immune response, a vaccination composition for protecting against a pestivirus-associated disease, a vector based on porcine pestivirus for delivering a heterologous polynucleotide sequence, a chimeric pestivirus for delivering a foreign polypeptide, an application of the vaccination composition, a method for detecting pestivirus, a diagnostic test system for detecting pestivirus, a method for producing a vaccine.
EFFECT: invention provides a possibility of obtaining an immunogenic pestivirus with good viral replication and a high potential for inducing immunity.
24 cl, 11 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BISPECIFIC ANTIBODY AGAINST RABIES VIRUS AND ITS APPLICATION | 2019 |
|
RU2764740C1 |
| METHOD FOR PRODUCTION OF ARENAVIRUS, AS WELL AS ARENAVIRUS MUTANTS WITH ANTITUMOR PROPERTIES | 2019 |
|
RU2812046C2 |
| PROMOTERS FOR ENHANCING EXPRESSION IN POXVIRUSES | 2016 |
|
RU2753884C2 |
| ATTENUATED PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (RRS) AND ITS POSSIBLE USE IN IMMUNIZATION MEANS | 2015 |
|
RU2723040C2 |
| MATERIALS AND METHODS USED FOR TREATMENT OF RESPIRATORY DISEASES IN DOGS | 2020 |
|
RU2811752C2 |
| AAV5-BASED VACCINE FOR INDUCTION OF SPECIFIC IMMUNITY TO SARS-COV-2 VIRUS AND/OR PREVENTION OF CORONAVIRUS INFECTION CAUSED BY SARS-COV-2 | 2020 |
|
RU2760301C1 |
| SELF-ASSEMBLED NANOSTRUCTURED VACCINES | 2019 |
|
RU2811439C2 |
| NEW CAPSID PROTEINS OF ADENO-ASSOCIATED VIRUS | 2017 |
|
RU2779318C2 |
| VACCINE BASED ON AAV5 FOR INDUCTION OF SPECIFIC IMMUNITY TO SARS-CoV-2 VIRUS AND/OR PREVENTION OF CORONAVIRUS INFECTION CAUSED BY SARS-CoV-2 | 2020 |
|
RU2783313C1 |
| F RSV PROTEIN MUTANTS | 2016 |
|
RU2788403C2 |
